TABLE 1.

Descriptive characteristics of the 31 subjects included in the study at the time of ELISPOT evaluation^a

Progressor category and subject no.	Age (yr)/sex	HLA locus			Absolute no. of T cells/μl		CD4 slope (cells/μl/yr)	Plasma viral load (HIV-1 RNA copies/ml)
		A	B	C	CD4	CD8
Typical
1	34/M	2, 11	14, 39	7, 8	425	935	88.7	5,741
2	25/M	2, 3	7, 14	7, 8	725	1450	98	982
3	34/M	2, 11	7, 14	7, 8	999	1,377	57	1,310
4	26/M	2, 26	15, 38	3, 12	504	2,412	34	3,952
5	27/M	3, 30	35, 40	2, 4	600	1,488	45	683
6	23/M	23, 26	15, 38	2, 12	504	1,568	61	12,420
7	42/M	2, 26	35, 40	2, 4	682	880	46	865
8	37/M	2, 36	15, 53	2, 4	510	1,700	77	1,494
9	44/M	2	43, 44	2, 5	660	1,034	35	72
10	18/M	2, 4	13, 15	3, 6	620	1,116	77	4,371
11	35/F	2, 11	27, 52	2, 12	589	798	79	119
12	36/M	2, 26	27, 62	1, 3	520	1,000	35.7	587
13	42/M	1, 2	44, 57	6, 16	840	1,428	98	638
14	33/M	2, 31	40, 44	3, 5	442	986	97.7	729
15	18/M	2	40, 47	2, 15	780	720	78	1,796
16	29/M	1, 2	8, 18	7	552	1,344	35	839
17	31/M	2, 24	15, 40	3	525	1,134	44	1,452
Slow
18	37/M	3	14	8	588	1,540	0	522
19	33/M	2, 24	18, 44	4, 5	660	1,144	0	564
20	40/M	1, 2	27, 44	2, 5	561	1,782	29	1,476
21	27/M	11, 29	27, 44	1, 16	924	980	0	913
22	38/M	33, 68	15, 35	3, 15	741	2,067	0	5,865
23	36/M	2, 24	7, 27	1, 7	429	689	28	17,700
24	29/M	2, 11	7, 35	4, 5	572	1,352	23	1,192
25	27/M	2, 33	14, 40	2, 8	630	735	9	20,876
Fast
26	28/M	2, 29	15, 27	1, 2	572	1,222	177	2,217
27	38/M	3, 26	7, 15	3, 7	567	1,029	128	6,395
28	39/M	1	18, 44	5, 6	572	1,034	140	6,425
29	27/M	1, 3	7, 57	7	494	912	150	22,065
30	51/M	1, 3	18, 57	5, 6	600	1,590	132	529
31	42/M	1, 24	8, 15	3, 7	374	1,342	125	6,304

^aM, male; F, female.